nodes	percent_of_prediction	percent_of_DWPC	metapath
Iloperidone—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.0721	0.126	CbGbCtD
Iloperidone—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.0721	0.126	CbGbCtD
Iloperidone—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.0599	0.104	CbGbCtD
Iloperidone—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0541	0.0942	CbGbCtD
Iloperidone—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0433	0.0754	CbGbCtD
Iloperidone—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0346	0.0603	CbGbCtD
Iloperidone—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.0331	0.0577	CbGbCtD
Iloperidone—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.0331	0.0577	CbGbCtD
Iloperidone—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.0293	0.051	CbGbCtD
Iloperidone—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0248	0.0433	CbGbCtD
Iloperidone—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0228	0.0396	CbGbCtD
Iloperidone—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0227	0.0395	CbGbCtD
Iloperidone—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0211	0.0367	CbGbCtD
Iloperidone—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0169	0.0295	CbGbCtD
Iloperidone—HTR1D—meninx—peripheral nervous system neoplasm	0.016	0.139	CbGeAlD
Iloperidone—HTR1D—dura mater—peripheral nervous system neoplasm	0.0147	0.128	CbGeAlD
Iloperidone—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00969	0.0169	CbGbCtD
Iloperidone—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00952	0.0166	CbGbCtD
Iloperidone—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00888	0.0155	CbGbCtD
Iloperidone—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.00861	0.0748	CbGeAlD
Iloperidone—HTR1D—trigeminal nerve—peripheral nervous system neoplasm	0.00634	0.0551	CbGeAlD
Iloperidone—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00605	0.0105	CbGbCtD
Iloperidone—Gefitinib—CHEK2—peripheral nervous system neoplasm	0.00483	0.768	CrCbGaD
Iloperidone—HTR7—vagus nerve—peripheral nervous system neoplasm	0.00472	0.041	CbGeAlD
Iloperidone—HTR1D—cranial nerve—peripheral nervous system neoplasm	0.00451	0.0392	CbGeAlD
Iloperidone—HTR6—ganglion—peripheral nervous system neoplasm	0.00392	0.034	CbGeAlD
Iloperidone—HTR7—cranial nerve—peripheral nervous system neoplasm	0.0036	0.0313	CbGeAlD
Iloperidone—HTR7—pons—peripheral nervous system neoplasm	0.00355	0.0309	CbGeAlD
Iloperidone—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.00315	0.0274	CbGeAlD
Iloperidone—DRD1—nerve—peripheral nervous system neoplasm	0.00295	0.0256	CbGeAlD
Iloperidone—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.00294	0.0256	CbGeAlD
Iloperidone—DRD1—ganglion—peripheral nervous system neoplasm	0.00291	0.0253	CbGeAlD
Iloperidone—HTR1D—ganglion—peripheral nervous system neoplasm	0.00228	0.0199	CbGeAlD
Iloperidone—HTR2C—ganglion—peripheral nervous system neoplasm	0.00226	0.0197	CbGeAlD
Iloperidone—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.00224	0.0195	CbGeAlD
Iloperidone—HTR2A—pons—peripheral nervous system neoplasm	0.00222	0.0193	CbGeAlD
Iloperidone—HTR1A—ganglion—peripheral nervous system neoplasm	0.0019	0.0166	CbGeAlD
Iloperidone—HTR7—nerve—peripheral nervous system neoplasm	0.00184	0.016	CbGeAlD
Iloperidone—HTR7—ganglion—peripheral nervous system neoplasm	0.00182	0.0158	CbGeAlD
Iloperidone—DRD2—nerve—peripheral nervous system neoplasm	0.00174	0.0151	CbGeAlD
Iloperidone—DRD2—ganglion—peripheral nervous system neoplasm	0.00172	0.015	CbGeAlD
Iloperidone—DRD1—brainstem—peripheral nervous system neoplasm	0.00127	0.011	CbGeAlD
Iloperidone—HTR2A—nerve—peripheral nervous system neoplasm	0.00115	0.00999	CbGeAlD
Iloperidone—HTR2A—ganglion—peripheral nervous system neoplasm	0.00114	0.00987	CbGeAlD
Iloperidone—HTR1D—trigeminal ganglion—peripheral nervous system neoplasm	0.00112	0.00976	CbGeAlD
Iloperidone—SIGMAR1—trigeminal ganglion—peripheral nervous system neoplasm	0.00105	0.00909	CbGeAlD
Iloperidone—HTR1D—brainstem—peripheral nervous system neoplasm	0.000993	0.00863	CbGeAlD
Iloperidone—SIGMAR1—parotid gland—peripheral nervous system neoplasm	0.000987	0.00858	CbGeAlD
Iloperidone—HTR2C—brainstem—peripheral nervous system neoplasm	0.000984	0.00855	CbGeAlD
Iloperidone—Risperidone—ABCB1—peripheral nervous system neoplasm	0.00087	0.138	CrCbGaD
Iloperidone—HTR1A—brainstem—peripheral nervous system neoplasm	0.000828	0.0072	CbGeAlD
Iloperidone—ADRA2C—trigeminal ganglion—peripheral nervous system neoplasm	0.000822	0.00714	CbGeAlD
Iloperidone—HTR7—brainstem—peripheral nervous system neoplasm	0.000791	0.00688	CbGeAlD
Iloperidone—ADRA2C—parotid gland—peripheral nervous system neoplasm	0.000775	0.00674	CbGeAlD
Iloperidone—ADRA1A—brainstem—peripheral nervous system neoplasm	0.000763	0.00663	CbGeAlD
Iloperidone—DRD2—brainstem—peripheral nervous system neoplasm	0.000748	0.0065	CbGeAlD
Iloperidone—HRH1—trigeminal ganglion—peripheral nervous system neoplasm	0.000668	0.0058	CbGeAlD
Iloperidone—ADRA2A—trigeminal ganglion—peripheral nervous system neoplasm	0.000656	0.0057	CbGeAlD
Iloperidone—Gefitinib—ABCB1—peripheral nervous system neoplasm	0.000587	0.0934	CrCbGaD
Iloperidone—HTR2A—brainstem—peripheral nervous system neoplasm	0.000493	0.00429	CbGeAlD
Iloperidone—SIGMAR1—cerebellum—peripheral nervous system neoplasm	0.000457	0.00397	CbGeAlD
Iloperidone—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000449	0.00391	CbGeAlD
Iloperidone—HTR1A—cerebellum—peripheral nervous system neoplasm	0.000408	0.00355	CbGeAlD
Iloperidone—HTR7—cerebellum—peripheral nervous system neoplasm	0.00039	0.00339	CbGeAlD
Iloperidone—ADRA1A—cerebellum—peripheral nervous system neoplasm	0.000376	0.00327	CbGeAlD
Iloperidone—DRD2—cerebellum—peripheral nervous system neoplasm	0.000369	0.00321	CbGeAlD
Iloperidone—ADRA2C—cerebellum—peripheral nervous system neoplasm	0.000359	0.00312	CbGeAlD
Iloperidone—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.000331	0.00127	CcSEcCtD
Iloperidone—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.000329	0.00127	CcSEcCtD
Iloperidone—Dry eye—Doxorubicin—peripheral nervous system neoplasm	0.000328	0.00126	CcSEcCtD
Iloperidone—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.000327	0.00126	CcSEcCtD
Iloperidone—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.000326	0.00126	CcSEcCtD
Iloperidone—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.000326	0.00126	CcSEcCtD
Iloperidone—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000326	0.00126	CcSEcCtD
Iloperidone—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000326	0.00126	CcSEcCtD
Iloperidone—Eye disorder—Etoposide—peripheral nervous system neoplasm	0.000321	0.00124	CcSEcCtD
Iloperidone—Mouth ulceration—Doxorubicin—peripheral nervous system neoplasm	0.000321	0.00123	CcSEcCtD
Iloperidone—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.000319	0.00123	CcSEcCtD
Iloperidone—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.000319	0.00123	CcSEcCtD
Iloperidone—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.000315	0.00121	CcSEcCtD
Iloperidone—Myalgia—Vincristine—peripheral nervous system neoplasm	0.000314	0.00121	CcSEcCtD
Iloperidone—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.000314	0.00121	CcSEcCtD
Iloperidone—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000313	0.0012	CcSEcCtD
Iloperidone—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.000312	0.0012	CcSEcCtD
Iloperidone—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000311	0.0012	CcSEcCtD
Iloperidone—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.00031	0.00119	CcSEcCtD
Iloperidone—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.000308	0.00118	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000307	0.00118	CcSEcCtD
Iloperidone—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000307	0.00118	CcSEcCtD
Iloperidone—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000306	0.00118	CcSEcCtD
Iloperidone—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000305	0.00117	CcSEcCtD
Iloperidone—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.000302	0.00116	CcSEcCtD
Iloperidone—Renal failure acute—Epirubicin—peripheral nervous system neoplasm	0.000302	0.00116	CcSEcCtD
Iloperidone—Oedema—Vincristine—peripheral nervous system neoplasm	0.000301	0.00116	CcSEcCtD
Iloperidone—Infection—Vincristine—peripheral nervous system neoplasm	0.0003	0.00115	CcSEcCtD
Iloperidone—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000299	0.00115	CcSEcCtD
Iloperidone—Increased appetite—Epirubicin—peripheral nervous system neoplasm	0.000296	0.00114	CcSEcCtD
Iloperidone—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000296	0.00114	CcSEcCtD
Iloperidone—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000296	0.00114	CcSEcCtD
Iloperidone—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000296	0.00114	CcSEcCtD
Iloperidone—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000292	0.00112	CcSEcCtD
Iloperidone—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000292	0.00112	CcSEcCtD
Iloperidone—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000292	0.00112	CcSEcCtD
Iloperidone—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000291	0.00112	CcSEcCtD
Iloperidone—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000288	0.00111	CcSEcCtD
Iloperidone—ADRA2A—cerebellum—peripheral nervous system neoplasm	0.000286	0.00249	CbGeAlD
Iloperidone—Cardiac failure—Epirubicin—peripheral nervous system neoplasm	0.000285	0.0011	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000285	0.0011	CcSEcCtD
Iloperidone—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000285	0.0011	CcSEcCtD
Iloperidone—Lethargy—Epirubicin—peripheral nervous system neoplasm	0.000284	0.00109	CcSEcCtD
Iloperidone—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000282	0.00109	CcSEcCtD
Iloperidone—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000282	0.00109	CcSEcCtD
Iloperidone—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000282	0.00108	CcSEcCtD
Iloperidone—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000281	0.00108	CcSEcCtD
Iloperidone—CYP2E1—cerebellum—peripheral nervous system neoplasm	0.00028	0.00243	CbGeAlD
Iloperidone—Renal failure acute—Doxorubicin—peripheral nervous system neoplasm	0.000279	0.00107	CcSEcCtD
Iloperidone—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000279	0.00107	CcSEcCtD
Iloperidone—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000279	0.00107	CcSEcCtD
Iloperidone—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000278	0.00107	CcSEcCtD
Iloperidone—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000278	0.00107	CcSEcCtD
Iloperidone—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000278	0.00107	CcSEcCtD
Iloperidone—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000277	0.00106	CcSEcCtD
Iloperidone—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000275	0.00106	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000275	0.00106	CcSEcCtD
Iloperidone—Increased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.00106	CcSEcCtD
Iloperidone—Affect lability—Epirubicin—peripheral nervous system neoplasm	0.000274	0.00105	CcSEcCtD
Iloperidone—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000273	0.00105	CcSEcCtD
Iloperidone—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000273	0.00105	CcSEcCtD
Iloperidone—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000271	0.00104	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00027	0.00104	CcSEcCtD
Iloperidone—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00027	0.00104	CcSEcCtD
Iloperidone—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000269	0.00103	CcSEcCtD
Iloperidone—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000268	0.00103	CcSEcCtD
Iloperidone—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000267	0.00103	CcSEcCtD
Iloperidone—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000267	0.00103	CcSEcCtD
Iloperidone—Infection—Cisplatin—peripheral nervous system neoplasm	0.000265	0.00102	CcSEcCtD
Iloperidone—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.000264	0.00102	CcSEcCtD
Iloperidone—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.000264	0.00102	CcSEcCtD
Iloperidone—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.00101	CcSEcCtD
Iloperidone—Rash—Topotecan—peripheral nervous system neoplasm	0.000262	0.00101	CcSEcCtD
Iloperidone—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000262	0.00101	CcSEcCtD
Iloperidone—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000261	0.00101	CcSEcCtD
Iloperidone—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00026	0.001	CcSEcCtD
Iloperidone—Rash—Tretinoin—peripheral nervous system neoplasm	0.00026	0.001	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00026	0.001	CcSEcCtD
Iloperidone—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00026	0.001	CcSEcCtD
Iloperidone—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00026	0.001	CcSEcCtD
Iloperidone—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00026	0.001	CcSEcCtD
Iloperidone—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00026	0.001	CcSEcCtD
Iloperidone—Dehydration—Epirubicin—peripheral nervous system neoplasm	0.000259	0.000996	CcSEcCtD
Iloperidone—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000258	0.000992	CcSEcCtD
Iloperidone—Rash—Melphalan—peripheral nervous system neoplasm	0.000257	0.000988	CcSEcCtD
Iloperidone—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000257	0.000987	CcSEcCtD
Iloperidone—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000254	0.000979	CcSEcCtD
Iloperidone—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.000976	CcSEcCtD
Iloperidone—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000253	0.000975	CcSEcCtD
Iloperidone—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000252	0.000968	CcSEcCtD
Iloperidone—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000249	0.000958	CcSEcCtD
Iloperidone—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000249	0.000958	CcSEcCtD
Iloperidone—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000247	0.000951	CcSEcCtD
Iloperidone—Nausea—Topotecan—peripheral nervous system neoplasm	0.000247	0.000951	CcSEcCtD
Iloperidone—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000948	CcSEcCtD
Iloperidone—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000246	0.000947	CcSEcCtD
Iloperidone—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000245	0.000943	CcSEcCtD
Iloperidone—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000245	0.000943	CcSEcCtD
Iloperidone—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.000939	CcSEcCtD
Iloperidone—HTR2A—cerebellum—peripheral nervous system neoplasm	0.000243	0.00211	CbGeAlD
Iloperidone—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000243	0.000934	CcSEcCtD
Iloperidone—Infection—Etoposide—peripheral nervous system neoplasm	0.000243	0.000933	CcSEcCtD
Iloperidone—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000242	0.000931	CcSEcCtD
Iloperidone—Nausea—Melphalan—peripheral nervous system neoplasm	0.000242	0.000931	CcSEcCtD
Iloperidone—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000241	0.000926	CcSEcCtD
Iloperidone—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.000922	CcSEcCtD
Iloperidone—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000239	0.000921	CcSEcCtD
Iloperidone—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000238	0.000917	CcSEcCtD
Iloperidone—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000238	0.000917	CcSEcCtD
Iloperidone—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000238	0.000914	CcSEcCtD
Iloperidone—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000906	CcSEcCtD
Iloperidone—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000902	CcSEcCtD
Iloperidone—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.000896	CcSEcCtD
Iloperidone—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000231	0.000888	CcSEcCtD
Iloperidone—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.00023	0.000887	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00023	0.000885	CcSEcCtD
Iloperidone—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000228	0.000878	CcSEcCtD
Iloperidone—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000877	CcSEcCtD
Iloperidone—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000225	0.000866	CcSEcCtD
Iloperidone—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000224	0.000864	CcSEcCtD
Iloperidone—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000224	0.000861	CcSEcCtD
Iloperidone—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000857	CcSEcCtD
Iloperidone—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000222	0.000856	CcSEcCtD
Iloperidone—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000222	0.00193	CbGeAlD
Iloperidone—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00022	0.000845	CcSEcCtD
Iloperidone—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000219	0.000844	CcSEcCtD
Iloperidone—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000843	CcSEcCtD
Iloperidone—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000218	0.000838	CcSEcCtD
Iloperidone—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000218	0.000838	CcSEcCtD
Iloperidone—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000217	0.000835	CcSEcCtD
Iloperidone—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000216	0.000832	CcSEcCtD
Iloperidone—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000214	0.000824	CcSEcCtD
Iloperidone—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000213	0.000818	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000211	0.000811	CcSEcCtD
Iloperidone—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000211	0.000811	CcSEcCtD
Iloperidone—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000211	0.00081	CcSEcCtD
Iloperidone—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000805	CcSEcCtD
Iloperidone—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000803	CcSEcCtD
Iloperidone—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000801	CcSEcCtD
Iloperidone—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000796	CcSEcCtD
Iloperidone—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000207	0.000796	CcSEcCtD
Iloperidone—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000206	0.000794	CcSEcCtD
Iloperidone—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000792	CcSEcCtD
Iloperidone—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000203	0.000781	CcSEcCtD
Iloperidone—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.00078	CcSEcCtD
Iloperidone—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000779	CcSEcCtD
Iloperidone—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.000775	CcSEcCtD
Iloperidone—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000201	0.000774	CcSEcCtD
Iloperidone—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.0002	0.000771	CcSEcCtD
Iloperidone—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000199	0.000767	CcSEcCtD
Iloperidone—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000197	0.000759	CcSEcCtD
Iloperidone—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000197	0.000758	CcSEcCtD
Iloperidone—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000745	CcSEcCtD
Iloperidone—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000193	0.000743	CcSEcCtD
Iloperidone—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000743	CcSEcCtD
Iloperidone—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000191	0.000736	CcSEcCtD
Iloperidone—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.00019	0.000732	CcSEcCtD
Iloperidone—Rash—Vincristine—peripheral nervous system neoplasm	0.00019	0.000731	CcSEcCtD
Iloperidone—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00019	0.000731	CcSEcCtD
Iloperidone—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000728	CcSEcCtD
Iloperidone—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000727	CcSEcCtD
Iloperidone—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000723	CcSEcCtD
Iloperidone—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000721	CcSEcCtD
Iloperidone—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000186	0.000715	CcSEcCtD
Iloperidone—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000182	0.000702	CcSEcCtD
Iloperidone—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000693	CcSEcCtD
Iloperidone—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000691	CcSEcCtD
Iloperidone—Nausea—Vincristine—peripheral nervous system neoplasm	0.000179	0.000689	CcSEcCtD
Iloperidone—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000688	CcSEcCtD
Iloperidone—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.000677	CcSEcCtD
Iloperidone—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000175	0.000674	CcSEcCtD
Iloperidone—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000674	CcSEcCtD
Iloperidone—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000673	CcSEcCtD
Iloperidone—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000672	CcSEcCtD
Iloperidone—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000174	0.000668	CcSEcCtD
Iloperidone—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000662	CcSEcCtD
Iloperidone—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000649	CcSEcCtD
Iloperidone—Rash—Cisplatin—peripheral nervous system neoplasm	0.000168	0.000647	CcSEcCtD
Iloperidone—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000168	0.000646	CcSEcCtD
Iloperidone—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000645	CcSEcCtD
Iloperidone—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000167	0.000643	CcSEcCtD
Iloperidone—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000641	CcSEcCtD
Iloperidone—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000639	CcSEcCtD
Iloperidone—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000637	CcSEcCtD
Iloperidone—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000622	CcSEcCtD
Iloperidone—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000162	0.000621	CcSEcCtD
Iloperidone—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000161	0.00062	CcSEcCtD
Iloperidone—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000618	CcSEcCtD
Iloperidone—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000613	CcSEcCtD
Iloperidone—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000158	0.000609	CcSEcCtD
Iloperidone—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000608	CcSEcCtD
Iloperidone—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000601	CcSEcCtD
Iloperidone—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000597	CcSEcCtD
Iloperidone—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000596	CcSEcCtD
Iloperidone—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000593	CcSEcCtD
Iloperidone—Rash—Etoposide—peripheral nervous system neoplasm	0.000154	0.000592	CcSEcCtD
Iloperidone—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000154	0.000592	CcSEcCtD
Iloperidone—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000151	0.00058	CcSEcCtD
Iloperidone—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000578	CcSEcCtD
Iloperidone—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000574	CcSEcCtD
Iloperidone—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000148	0.00057	CcSEcCtD
Iloperidone—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000563	CcSEcCtD
Iloperidone—Nausea—Etoposide—peripheral nervous system neoplasm	0.000145	0.000558	CcSEcCtD
Iloperidone—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000552	CcSEcCtD
Iloperidone—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000549	CcSEcCtD
Iloperidone—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000549	CcSEcCtD
Iloperidone—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000549	CcSEcCtD
Iloperidone—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000537	CcSEcCtD
Iloperidone—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000536	CcSEcCtD
Iloperidone—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000534	CcSEcCtD
Iloperidone—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000531	CcSEcCtD
Iloperidone—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000528	CcSEcCtD
Iloperidone—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000527	CcSEcCtD
Iloperidone—Infection—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000523	CcSEcCtD
Iloperidone—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000516	CcSEcCtD
Iloperidone—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000514	CcSEcCtD
Iloperidone—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000508	CcSEcCtD
Iloperidone—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000508	CcSEcCtD
Iloperidone—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000497	CcSEcCtD
Iloperidone—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000492	CcSEcCtD
Iloperidone—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000491	CcSEcCtD
Iloperidone—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000487	CcSEcCtD
Iloperidone—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000484	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000125	0.00048	CcSEcCtD
Iloperidone—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000478	CcSEcCtD
Iloperidone—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000476	CcSEcCtD
Iloperidone—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000473	CcSEcCtD
Iloperidone—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000122	0.00047	CcSEcCtD
Iloperidone—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000468	CcSEcCtD
Iloperidone—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000455	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000455	CcSEcCtD
Iloperidone—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000454	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000444	CcSEcCtD
Iloperidone—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000438	CcSEcCtD
Iloperidone—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000434	CcSEcCtD
Iloperidone—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000434	CcSEcCtD
Iloperidone—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000433	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000421	CcSEcCtD
Iloperidone—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.00042	CcSEcCtD
Iloperidone—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000416	CcSEcCtD
Iloperidone—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000402	CcSEcCtD
Iloperidone—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000385	CcSEcCtD
Iloperidone—Asthenia—Epirubicin—peripheral nervous system neoplasm	9.82e-05	0.000378	CcSEcCtD
Iloperidone—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	9.37e-05	0.00036	CcSEcCtD
Iloperidone—Asthenia—Doxorubicin—peripheral nervous system neoplasm	9.09e-05	0.00035	CcSEcCtD
Iloperidone—Dizziness—Epirubicin—peripheral nervous system neoplasm	9.05e-05	0.000348	CcSEcCtD
Iloperidone—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	8.67e-05	0.000333	CcSEcCtD
Iloperidone—Rash—Epirubicin—peripheral nervous system neoplasm	8.63e-05	0.000332	CcSEcCtD
Iloperidone—Dermatitis—Epirubicin—peripheral nervous system neoplasm	8.62e-05	0.000332	CcSEcCtD
Iloperidone—Dizziness—Doxorubicin—peripheral nervous system neoplasm	8.38e-05	0.000322	CcSEcCtD
Iloperidone—Nausea—Epirubicin—peripheral nervous system neoplasm	8.13e-05	0.000313	CcSEcCtD
Iloperidone—Rash—Doxorubicin—peripheral nervous system neoplasm	7.99e-05	0.000307	CcSEcCtD
Iloperidone—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	7.98e-05	0.000307	CcSEcCtD
Iloperidone—Nausea—Doxorubicin—peripheral nervous system neoplasm	7.52e-05	0.000289	CcSEcCtD
Iloperidone—DRD3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.5e-05	0.000336	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.49e-05	0.000335	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.49e-05	0.000334	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.48e-05	0.000334	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—ABCB1—peripheral nervous system neoplasm	1.48e-05	0.000333	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.48e-05	0.000332	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—BCHE—peripheral nervous system neoplasm	1.47e-05	0.00033	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	1.46e-05	0.000329	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.44e-05	0.000324	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.42e-05	0.00032	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.41e-05	0.000318	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.4e-05	0.000315	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.4e-05	0.000314	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—TH—peripheral nervous system neoplasm	1.38e-05	0.00031	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	1.38e-05	0.000309	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.38e-05	0.000309	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.37e-05	0.000308	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.35e-05	0.000303	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	1.33e-05	0.000299	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.33e-05	0.000298	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.32e-05	0.000297	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.31e-05	0.000294	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.3e-05	0.000293	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.3e-05	0.000292	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.3e-05	0.000292	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.29e-05	0.00029	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.29e-05	0.000289	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	1.27e-05	0.000287	CbGpPWpGaD
Iloperidone—ADRA2A—Hemostasis—NRAS—peripheral nervous system neoplasm	1.26e-05	0.000284	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.26e-05	0.000284	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.26e-05	0.000284	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.25e-05	0.000281	CbGpPWpGaD
Iloperidone—HTR6—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.25e-05	0.00028	CbGpPWpGaD
Iloperidone—HTR7—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.25e-05	0.00028	CbGpPWpGaD
Iloperidone—HTR1D—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.24e-05	0.000278	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	1.23e-05	0.000277	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.23e-05	0.000276	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	1.23e-05	0.000276	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—GNAS—peripheral nervous system neoplasm	1.23e-05	0.000276	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.23e-05	0.000275	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.22e-05	0.000275	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.22e-05	0.000275	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.22e-05	0.000273	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.21e-05	0.000271	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—ABCB1—peripheral nervous system neoplasm	1.2e-05	0.00027	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.2e-05	0.00027	CbGpPWpGaD
Iloperidone—DRD4—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.19e-05	0.000268	CbGpPWpGaD
Iloperidone—ADRA2C—Hemostasis—TP53—peripheral nervous system neoplasm	1.19e-05	0.000268	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.17e-05	0.000264	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.17e-05	0.000263	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.15e-05	0.000257	CbGpPWpGaD
Iloperidone—ADRA2C—Hemostasis—HRAS—peripheral nervous system neoplasm	1.14e-05	0.000256	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.13e-05	0.000253	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—GNAS—peripheral nervous system neoplasm	1.13e-05	0.000253	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.12e-05	0.000253	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	1.12e-05	0.000253	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.12e-05	0.000251	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.11e-05	0.000248	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.1e-05	0.000248	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	1.1e-05	0.000248	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.07e-05	0.000241	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.06e-05	0.000238	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.05e-05	0.000237	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	1.04e-05	0.000235	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	1.04e-05	0.000234	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.04e-05	0.000234	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.03e-05	0.00023	CbGpPWpGaD
Iloperidone—ADRA2C—Hemostasis—AKT1—peripheral nervous system neoplasm	1.01e-05	0.000226	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.93e-06	0.000223	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	9.79e-06	0.00022	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.68e-06	0.000218	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.67e-06	0.000217	CbGpPWpGaD
Iloperidone—ADRA2A—Hemostasis—TP53—peripheral nervous system neoplasm	9.67e-06	0.000217	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.61e-06	0.000216	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.26e-06	0.000208	CbGpPWpGaD
Iloperidone—ADRA2A—Hemostasis—HRAS—peripheral nervous system neoplasm	9.25e-06	0.000208	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.23e-06	0.000207	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.18e-06	0.000206	CbGpPWpGaD
Iloperidone—HTR6—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.12e-06	0.000205	CbGpPWpGaD
Iloperidone—HTR7—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.11e-06	0.000205	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.07e-06	0.000204	CbGpPWpGaD
Iloperidone—HTR1D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.05e-06	0.000203	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.02e-06	0.000203	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.93e-06	0.000201	CbGpPWpGaD
Iloperidone—HTR6—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.87e-06	0.000199	CbGpPWpGaD
Iloperidone—HTR7—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.86e-06	0.000199	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	8.82e-06	0.000198	CbGpPWpGaD
Iloperidone—HTR1D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.8e-06	0.000198	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.79e-06	0.000197	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.78e-06	0.000197	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.77e-06	0.000197	CbGpPWpGaD
Iloperidone—DRD4—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.72e-06	0.000196	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.72e-06	0.000196	CbGpPWpGaD
Iloperidone—DRD4—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.48e-06	0.000191	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.41e-06	0.000189	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.4e-06	0.000189	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.33e-06	0.000187	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	8.29e-06	0.000186	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.22e-06	0.000185	CbGpPWpGaD
Iloperidone—ADRA2A—Hemostasis—AKT1—peripheral nervous system neoplasm	8.16e-06	0.000183	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.1e-06	0.000182	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	8.06e-06	0.000181	CbGpPWpGaD
Iloperidone—HTR6—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.05e-06	0.000181	CbGpPWpGaD
Iloperidone—HTR7—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.04e-06	0.000181	CbGpPWpGaD
Iloperidone—HTR1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.99e-06	0.00018	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	7.99e-06	0.00018	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.97e-06	0.000179	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.96e-06	0.000179	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.96e-06	0.000179	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.85e-06	0.000176	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	7.84e-06	0.000176	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.83e-06	0.000176	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.82e-06	0.000176	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.81e-06	0.000175	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.75e-06	0.000174	CbGpPWpGaD
Iloperidone—DRD4—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.7e-06	0.000173	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.67e-06	0.000172	CbGpPWpGaD
Iloperidone—DRD1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.63e-06	0.000172	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.56e-06	0.00017	CbGpPWpGaD
Iloperidone—DRD3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.53e-06	0.000169	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.46e-06	0.000168	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.36e-06	0.000166	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.36e-06	0.000165	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.31e-06	0.000164	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.25e-06	0.000163	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.17e-06	0.000161	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.13e-06	0.00016	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.13e-06	0.00016	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.04e-06	0.000158	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.93e-06	0.000156	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.93e-06	0.000156	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.86e-06	0.000154	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.85e-06	0.000154	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.84e-06	0.000154	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.81e-06	0.000153	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	6.81e-06	0.000153	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	6.77e-06	0.000152	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.75e-06	0.000152	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.72e-06	0.000151	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	6.64e-06	0.000149	CbGpPWpGaD
Iloperidone—HTR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.56e-06	0.000148	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.56e-06	0.000147	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.53e-06	0.000147	CbGpPWpGaD
Iloperidone—HTR2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.53e-06	0.000147	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.5e-06	0.000146	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.49e-06	0.000146	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.47e-06	0.000145	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	6.4e-06	0.000144	CbGpPWpGaD
Iloperidone—ADRA2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.35e-06	0.000143	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.34e-06	0.000142	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.29e-06	0.000141	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.29e-06	0.000141	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.26e-06	0.000141	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.19e-06	0.000139	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.18e-06	0.000139	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.06e-06	0.000136	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.96e-06	0.000134	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.93e-06	0.000133	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.93e-06	0.000133	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.91e-06	0.000133	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.83e-06	0.000131	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.83e-06	0.000131	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.82e-06	0.000131	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.77e-06	0.00013	CbGpPWpGaD
Iloperidone—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.76e-06	0.00013	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.71e-06	0.000128	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.71e-06	0.000128	CbGpPWpGaD
Iloperidone—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.67e-06	0.000127	CbGpPWpGaD
Iloperidone—HRH1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.66e-06	0.000127	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.63e-06	0.000127	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.63e-06	0.000127	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.63e-06	0.000126	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.62e-06	0.000126	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.61e-06	0.000126	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.59e-06	0.000126	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.55e-06	0.000125	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.5e-06	0.000124	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.45e-06	0.000123	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.42e-06	0.000122	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.39e-06	0.000121	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.39e-06	0.000121	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.38e-06	0.000121	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.35e-06	0.00012	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.31e-06	0.000119	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.28e-06	0.000119	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.23e-06	0.000118	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	5.22e-06	0.000117	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.16e-06	0.000116	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.15e-06	0.000116	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.15e-06	0.000116	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.14e-06	0.000115	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	5.13e-06	0.000115	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.11e-06	0.000115	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.08e-06	0.000114	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.05e-06	0.000114	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.04e-06	0.000113	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.91e-06	0.00011	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.85e-06	0.000109	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.79e-06	0.000108	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.79e-06	0.000108	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.76e-06	0.000107	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.75e-06	0.000107	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.72e-06	0.000106	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.71e-06	0.000106	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.7e-06	0.000106	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.69e-06	0.000105	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.64e-06	0.000104	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.61e-06	0.000104	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.58e-06	0.000103	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.55e-06	0.000102	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.46e-06	0.0001	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.39e-06	9.86e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.38e-06	9.84e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.3e-06	9.65e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.28e-06	9.63e-05	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—AKT1—peripheral nervous system neoplasm	4.2e-06	9.43e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.17e-06	9.37e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.15e-06	9.32e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.1e-06	9.2e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—AKT1—peripheral nervous system neoplasm	4.08e-06	9.16e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.04e-06	9.08e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.04e-06	9.07e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.99e-06	8.97e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.99e-06	8.96e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.97e-06	8.92e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.86e-06	8.67e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.66e-06	8.23e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.6e-06	8.1e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.6e-06	8.08e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.53e-06	7.93e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.52e-06	7.91e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.5e-06	7.87e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.5e-06	7.87e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.45e-06	7.74e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.44e-06	7.73e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.41e-06	7.66e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.37e-06	7.58e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—AKT1—peripheral nervous system neoplasm	3.31e-06	7.44e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.28e-06	7.37e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.13e-06	7.05e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.09e-06	6.95e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.04e-06	6.84e-05	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—AKT1—peripheral nervous system neoplasm	3.04e-06	6.83e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.04e-06	6.82e-05	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	3.03e-06	6.82e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.98e-06	6.7e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.77e-06	6.22e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	2.16e-06	4.85e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	1.83e-06	4.11e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.41e-06	3.17e-05	CbGpPWpGaD
